NCT00406003 - Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2006

Primary Completion Date

April 26, 2006

Study Completion Date

April 26, 2006

Conditions

Depressive Disorder

Interventions

DRUG

Paroxetine controlled release tablet

Paroxetine will be given as single dose, controlled release tablet with dosing strengths of 12.5, 25 and 37.5 milligrams in fasted state separated by a wash-out period of 10 days.

Trial Locations (1)

100730

GSK Investigational Site, Beijing